Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
biotech
deals
boston blog main
boston top stories
clinical trials
fda
national top stories
new york blog main
alnylam pharmaceuticals
boston
cancer
detroit blog main
detroit top stories
europe blog main
europe top stories
m&a
new york top stories
novartis
raleigh-durham blog main
san diego blog main
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
startups
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
accenture
advocate aurora health
akouos
alexion pharmaceuticals
alirocumab
allergan
amag pharmaceuticals
amgen
What
deal
7
×
billion
medicines
acquire
cash
company
drug
fda
help
medical
acquisitions
adding
adds
agreed
aims
alternative
announced
approval
autoimmune
betting
bio
biopharma
brings
candidate
catch
ceo
cholesterol
collabs
communities
compound
covid
daniel
decisions
device
diagnostic
diagnostics
disease
duchenne
epic
expand
Language
unset
7
×
Current search:
xconomy.com
×
deal
×
unset
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
WI Watchlist: Epic, Shine, Venture Investors, Stratatech & More